ENTITY
GSK

GSK (GSK US)

31
Analysis
Health CareUnited States
GSK PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GSK provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
more
bullishIndegene
19 Apr 2023 10:51

Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth

Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm...

Logo
493 Views
Share
bullishMankind Pharma
18 Apr 2023 17:04

Mankind Pharma Pre-IPO - RHP Updates - A Mixed Bag

Mankind Pharma  (MP) is now looking to raise around US$500m in its upcoming India IPO. In this note we talk about the updates from its recently...

Logo
350 Views
Share
bullishGSK
14 Dec 2022 01:25

GlaxoSmithKline ADR: Initiation of Coverage – Business Strategy & Other Drivers

This is our first report on GlaxoSmithKline (GSK), one of the largest pharmaceutical companies in the world. The company is making a significant...

Logo
300 Views
Share
bearishCopper
28 Jun 2022 23:38

Signs of Disinflation?; Commodities Deteriorating; Another Bear Market Bounce; Pharma/Biotech Buys

A bear market bounce is underway after the SPX, QQQ, and IWM found support at their respective downtrend channels. Until these indexes can break...

Logo
350 Views
Share
bullishNexon
14 May 2022 00:19

Japan Emerging as Leadership; Actionable Themes: Japan and Defensives

Despite the intact downtrend on Japan's TOPIX, relative strength is reversing topside a 4.5-year downtrend; this tells us Japan is emerging as...

Logo
552 Views
Share
x